Board Meeting AJANTA PHARMA LTD. - 532331 - Board Meeting Outcome for Approving Buyback Of Equity Shares BSE India The Board of Directors of the Company, at its meeting held today, i.e., March 10, 2023, has inter-alia considered and approved Buyback of 22,10,500 fully paid-up Equity Shares of face value of ? 2/- each by the Company (representing 2.59% of the total number of Equity Shares of the Company as of March 31, 2022 (not adjusted for bonus issue undertaken by Company as on June 24, 2022 ) at a price of ? 1,425/- (Indian Rupees One Thousand Four Hundred Twenty Five only) per Equity Share payable in cash for a total consideration not exceeding ? 315 crores (Indian Rupees Three Hundred and Fifteen crores only) (excluding transaction costs such as fees, brokerage, taxes, duties, etc.), which represents 9.93% and 9.64% of the aggregate of the Company's paid-up capital and free reserves as per the standalone and consolidated audited financials of the Company for the year ended as on March 31, 2022 respectively.